BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 29364548)

  • 21. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical use of micafungin for the treatment of invasive candidiasis in critical ill patients].
    Pozo-Laderas JC
    Rev Iberoam Micol; 2009 Mar; 26(1):69-74. PubMed ID: 19463281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
    Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
    BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between the effectiveness and dose of micafungin in the treatment of candidemia].
    Sugawara T; Murakami N; Uetake N; Matsumoto S; Miyamori S; Okamoto R; Hiraki K
    Yakugaku Zasshi; 2014; 134(3):433-8. PubMed ID: 24584025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
    Kuse ER; Chetchotisakd P; da Cunha CA; Ruhnke M; Barrios C; Raghunadharao D; Sekhon JS; Freire A; Ramasubramanian V; Demeyer I; Nucci M; Leelarasamee A; Jacobs F; Decruyenaere J; Pittet D; Ullmann AJ; Ostrosky-Zeichner L; Lortholary O; Koblinger S; Diekmann-Berndt H; Cornely OA;
    Lancet; 2007 May; 369(9572):1519-1527. PubMed ID: 17482982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.
    Horn DL; Ostrosky-Zeichner L; Morris MI; Ullmann AJ; Wu C; Buell DN; Kovanda LL; Cornely OA
    Eur J Clin Microbiol Infect Dis; 2010 Feb; 29(2):223-9. PubMed ID: 20013016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant.
    Auriti C; Piersigilli F; Ronchetti MP; Campi F; Amante PG; Falcone M; Goffredo BM
    J Antimicrob Chemother; 2016 Jul; 71(7):2060-1. PubMed ID: 27009029
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.
    Dupont BF; Lortholary O; Ostrosky-Zeichner L; Stucker F; Yeldandi V
    Crit Care; 2009; 13(5):R159. PubMed ID: 19804626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!
    Gumbo T
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S635-42. PubMed ID: 26567282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
    BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study.
    Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR
    BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
    Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
    Kullberg BJ; Vasquez J; Mootsikapun P; Nucci M; Paiva JA; Garbino J; Yan JL; Aram J; Capparella MR; Conte U; Schlamm H; Swanson R; Herbrecht R
    J Antimicrob Chemother; 2017 Aug; 72(8):2368-2377. PubMed ID: 28459966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
    Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
    Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.